G.R. No. 163858 - United Laboratories Inc. vs. Isip

Case Summary (G.R. No. 163858)

Factual Background

The NBI, through Special Investigator Rolando H. Besarra, filed an application for a search warrant to inspect the first and second floors of the Shalimar Building located at the corner of Aragon Street and Lacson Avenue, Sta. Cruz, Manila, occupied by Shalimar Philippines and owned or operated by respondent Ernesto Isip. The warrant application sought seizure of finished or unfinished products of UNITED LABORATORIES (UNILAB), particularly REVICON multivitamins; sundry packaging and paraphernalia used in counterfeit distribution; and books, invoices and other documents evidencing manufacture or distribution of counterfeit REVICON. The application included a sketch, the affidavit of an undercover asset, a complaint letter from UNILAB, and a joint NBI affidavit describing alleged clandestine counterfeiting on the first and second floors.

Issuance and Execution of the Warrant

After hearing testimony, including that of a UNILAB representative, the RTC issued Search Warrant No. 04-4916 dated January 27, 2004, directing the seizure specified in the affidavit. The warrant was executed the same day by NBI agents Besarra and Divinagracia, in coordination with UNILAB employees. No counterfeit REVICON multivitamins were discovered. The executing officers opened sealed boxes found on the premises that, in the presence of respondent Isip, contained 792 bottles of Disudrin 60 ml. syrup and 30 boxes of Inoflox 200 mg. tablets. The NBI filed a return and inventory and requested that samples be turned over to the BFAD for examination.

Administrative and BFAD Findings

The BFAD examined samples of the seized products. Its report stated that the Disudrin syrup and the Inoflox tablets were registered products of UNILAB but that their label or physical appearance did not conform with BFAD-approved specifications. The BFAD further reported that the substances failed the test it performed.

Trial Court Proceedings

Respondents filed an Urgent Motion to Quash the Search Warrant or to Suppress Evidence, contending that the warrant authorized a search of the first and second floors of the Shalimar Building at No. 1571 Aragon Street, while the NBI had conducted searches at premises described as No. 1524-A Lacson Avenue, and that the seized Disudrin and Inoflox were not among the items described in the warrant. UNILAB and the NBI opposed the motion and asserted that the premises searched were the same building albeit described by an old and new address, and that the seized items were lawfully taken under the plain view doctrine. On March 11, 2004, the trial court granted the respondents’ motion and quashed the warrant on the ground that the seized articles were not those described in the warrant. The court on March 16, 2004 declared that the seized articles could not be admitted in evidence. UNILAB sought reconsideration, which the trial court denied on May 28, 2004, holding that the warrant was “crystal clear” and limited to counterfeit REVICON and related documents, and that seizure of other products was a fatal infirmity.

Petition and Issues Raised Before the Supreme Court

UNILAB filed a petition for review under Rule 45, Rules of Court. The petition presented three principal issues: whether the petitioner was the proper party to contest the trial court orders; whether the petition was properly filed directly with the Supreme Court; and whether the search and seizure of the sealed boxes and their contents were lawful, particularly under the plain view doctrine. UNILAB argued that the description "finished or unfinished products of UNILAB" embraced counterfeits and that the sealed boxes bore UNILAB marks and license plates that made their incriminating character immediately apparent. Respondents argued lack of locus standi by UNILAB, improper forum, that the seizure occurred at a different parcel and title than described in the warrant, and that the seized items were not listed in the warrant and were not illegal per se.

Legal Questions Framed by the Court

The Court framed the questions as whether a private complainant may defend the validity of a search warrant and the admissibility of seized properties; whether direct resort to the Supreme Court was warranted; and whether the plain view doctrine justified seizure of items not described in the warrant. The Court also considered whether the trial court deprived UNILAB of due process by ruling on a ground not expressly raised by respondents.

Standing and Proper Forum: Court's Analysis

The Court held that proceedings for a search warrant are not, in substance, criminal actions but special remedies for discovery and possession of personal property to aid public prosecution. It recognized that a private complainant or corporation that initiated the complaint may appear and participate in search warrant proceedings, and may resist motions to quash or move for reconsideration in collaboration with the enforcing agency. The Court cited authority permitting private complainants to be treated as parties for purposes of appellate review and concluded that, under the circumstances and given precedents such as 20th Century Fox Film Corporation v. Court of Appeals and Columbia Pictures Entertainment, Inc. v. Court of Appeals, UNILAB could be heard and the petition would be given due course despite being filed directly in the Supreme Court.

Particularity Requirement and the Plain View Doctrine: Governing Principles

The Court reiterated the constitutional and procedural requirement that a search warrant must particularly describe the place to be searched and the things to be seized, and that executing officers may seize only those things specifically described. The Court summarized the elements of the plain view doctrine as articulated in prior precedent and foreign decisions: (a) a prior justification for the initial intrusion or lawful position to view the object; (b) inadvertent discovery; and (c) that the incriminating character of the object be immediately apparent to the officer. The Court emphasized that immediate apparentness requires that the executing officer, by instantaneous sensory perception at the time of discovery, can form probable cause to associate the object with criminal activity.

Application of the Law to the Facts

The Court found that the warrant explicitly authorized seizure of counterfeit REVICON multivitamins and related documents, and that the seized Disudrin and Inoflox were not listed. The burden rested on the NBI and UNILAB to prove that the plain view exception applied. The Court observed that neither the NBI agents who executed the warrant nor any UNILAB representative who witnessed the seizure testified at the hearing to establish the essential elements of the plain view doctrine. There was no showing that the agents knew the contents of the sealed boxes prior to opening them, that discovery was inadvertent, or that the incriminating character of the boxes was immediately apparent at the moment of seizure. The Court held that mere presence of UNILAB markings on boxes and unproduced assertions about license plates or box markings were insufficient without testimonial proof by the exec

Case Syllabus (G.R. No. 163858)

Parties and Procedural Posture

UNITED LABORATORIES, INC. was the private complainant and petitioner who sought enforcement of a search warrant and the admission of seized merchandise in subsequent proceedings.
ERNESTO ISIP AND/OR SHALIMAR PHILIPPINES AND/OR OCCUPANTS were the respondents against whom the search warrant was directed and who moved to quash the warrant and suppress the seized items.
The application for the search warrant was filed by NBI Special Investigator Rolando H. Besarra and was docketed as People v. Ernesto Isip, Search Warrant Case No. 04-4916 in Branch 24 of the Regional Trial Court of Manila.
The search warrant authorized a search for and seizure of finished or unfinished UNILAB products, particularly REVICON multivitamins, sundry paraphernalia used in offering counterfeit REVICON, and business documents allegedly evidencing counterfeiting under Section 4(a), in relation to Section 8, of R.A. No. 8203.
The petitioner filed a petition for review under Rule 45 of the Rules of Court from the trial court orders quashing the warrant and declaring the seized items inadmissible.

Key Factual Allegations

An asset of the Armadillo Protection and Security Agency, Charlie Rabe, averred by affidavit that he witnessed manufacture and distribution of counterfeit REVICON at the Shalimar Building and provided photographs and a sketch appended to the application.
The search warrant issued directed the search of the first and second floors of the Shalimar Building located at No. 1571 Aragon Street, Sta. Cruz, Manila.
The warrant was implemented on January 27, 2004, at 4:30 p.m. by NBI agents Besarra and Divinagracia in coordination with UNILAB employees.
The NBI agents did not find counterfeit REVICON but opened sealed boxes which contained 792 bottles of Disudrin 60 ml. and 30 boxes (100 pieces each) of Inoflox 200 mg.
The NBI agents filed an inventory and return of the search warrant and requested that samples be turned over to the BFAD for assay.
The BFAD later reported that the examined Disudrin and Inoflox samples failed tests and that the label/physical appearance did not conform to registered specifications.

Procedural History

The trial court issued Search Warrant No. 04-4916 dated January 27, 2004 pursuant to the NBI application.
The respondents filed an Urgent Motion to Quash the Search Warrant and to Suppress Evidence asserting that the search was conducted at a different address and that seized items were not those described in the warrant.
The trial court granted the respondents' motion and on March 16, 2004 advised that the seized articles could no longer be admitted in evidence.
UNILAB, in collaboration with the NBI, moved for reconsideration which the trial court denied on May 28, 2004.
UNILAB filed the present petition for review on certiorari under Rule 45 with this Court challenging the trial court orders.

Issues Presented

Whether the seized 792 bottles of Disudrin and 30 boxes of Inoflox were inadmissible as fruits of an unlawful search.
Whether the seizure of the seized drugs was lawful under the plain view doctrine.
Whether UNILAB had the locus and the right to file and prosecute the petition in this Court.
Whether the present petition was properly filed directly with this Court under Rule 45.

Contentions of the Parties

UNILAB contended that the description in the search warrant of "finished or unfinished products of UNILAB" was sufficiently particular to include counterfeit versions of